chr4-158669744-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001008393.4(C4orf46):c.211C>A(p.Leu71Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000374 in 1,604,224 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 11/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001008393.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
C4orf46 | NM_001008393.4 | c.211C>A | p.Leu71Ile | missense_variant | 2/2 | ENST00000379205.5 | |
C4orf46 | NR_077234.2 | n.85C>A | non_coding_transcript_exon_variant | 2/2 | |||
C4orf46 | NR_077235.2 | n.81C>A | non_coding_transcript_exon_variant | 2/2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
C4orf46 | ENST00000379205.5 | c.211C>A | p.Leu71Ile | missense_variant | 2/2 | 1 | NM_001008393.4 | P1 | |
C4orf46 | ENST00000508836.1 | n.284C>A | non_coding_transcript_exon_variant | 2/2 | 1 | ||||
C4orf46 | ENST00000508457.1 | c.*9C>A | 3_prime_UTR_variant | 2/2 | 5 |
Frequencies
GnomAD3 genomes AF: 0.00000659 AC: 1AN: 151658Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000166 AC: 4AN: 240772Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 130280
GnomAD4 exome AF: 0.00000344 AC: 5AN: 1452566Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 721992
GnomAD4 genome AF: 0.00000659 AC: 1AN: 151658Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74018
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 09, 2021 | The c.211C>A (p.L71I) alteration is located in exon 2 (coding exon 2) of the C4orf46 gene. This alteration results from a C to A substitution at nucleotide position 211, causing the leucine (L) at amino acid position 71 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at